Innovative Therapeutics in Hemostasis Laboratory France

Research

Date range: 1 December 2020 - 30 November 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Innovative Therapeutics in Hemostasis Laboratory published between 1 December 2020 - 30 November 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Innovative Therapeutics in Hemostasis Laboratory
Count Share
2 0.08

Outputs by subject (Share)

Outputs by subject
Subject Count Share
2 0.08

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.00 0.00 0.00 0.03 0.08

Compare Innovative Therapeutics in Hemostasis Laboratory with other institutions

Collaboration

Date range: 1 December 2020 - 30 November 2021

International vs. domestic collaboration by Share

  • 77.73% Domestic
  • 22.27% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Innovative Therapeutics in Hemostasis Laboratory by Share (45 total)

  1. Innovative Therapeutics in Hemostasis Laboratory and Paris-Cardiovascular Research Center (PARCC) (0.59)
    Innovative Therapeutics in Hemostasis Laboratory0.07
    Paris-Cardiovascular Research Center (PARCC)0.52
  2. Innovative Therapeutics in Hemostasis Laboratory and National Institute for Health and Medical Research (INSERM) (0.47)
    Innovative Therapeutics in Hemostasis Laboratory0.08
    National Institute for Health and Medical Research (INSERM)0.40
  3. Innovative Therapeutics in Hemostasis Laboratory and University of Paris (0.36)
    Innovative Therapeutics in Hemostasis Laboratory0.08
    University of Paris0.29
  4. Innovative Therapeutics in Hemostasis Laboratory and Assistance Publique-Hôpitaux de Paris (AP-HP) (0.19)
    Innovative Therapeutics in Hemostasis Laboratory0.08
    Assistance Publique-Hôpitaux de Paris (AP-HP)0.11
  5. Innovative Therapeutics in Hemostasis Laboratory and Mediterranean Centre for Molecular Medicine (C3M) (0.19)
    Innovative Therapeutics in Hemostasis Laboratory0.07
    Mediterranean Centre for Molecular Medicine (C3M)0.11
  6. Innovative Therapeutics in Hemostasis Laboratory and Inotrem SA (0.15)
    Innovative Therapeutics in Hemostasis Laboratory0.07
    Inotrem SA0.07
  7. Innovative Therapeutics in Hemostasis Laboratory and University of Côte d'Azur (UCA) (0.13)
    Innovative Therapeutics in Hemostasis Laboratory0.07
    University of Côte d'Azur (UCA)0.06
  8. Innovative Therapeutics in Hemostasis Laboratory and Risk Factors and Molecular Determinants of Aging-related Diseases (RID-AGE) (0.11)
    Innovative Therapeutics in Hemostasis Laboratory0.08
    Risk Factors and Molecular Determinants of Aging-related Diseases (RID-AGE)0.04
  9. Innovative Therapeutics in Hemostasis Laboratory and Centre d'Immunologie et des Maladies Infectieuses (CIMI) (0.11)
    Innovative Therapeutics in Hemostasis Laboratory0.07
    Centre d'Immunologie et des Maladies Infectieuses (CIMI)0.04
  10. Innovative Therapeutics in Hemostasis Laboratory and Université Sorbonne Paris-Cité (USPC) (0.10)
    Innovative Therapeutics in Hemostasis Laboratory0.08
    Université Sorbonne Paris-Cité (USPC)0.03

Top 10 international collaborators with Innovative Therapeutics in Hemostasis Laboratory by Share (126 total)

  1. Innovative Therapeutics in Hemostasis Laboratory and University of Cambridge (0.11)
    Innovative Therapeutics in Hemostasis Laboratory0.07
    University of Cambridge0.04
  2. Innovative Therapeutics in Hemostasis Laboratory and Leiden University (0.07)
    Innovative Therapeutics in Hemostasis Laboratory0.00
    Leiden University0.07
  3. Innovative Therapeutics in Hemostasis Laboratory and Harvard University (0.07)
    Innovative Therapeutics in Hemostasis Laboratory0.00
    Harvard University0.07
  4. Innovative Therapeutics in Hemostasis Laboratory and Erasmus University Rotterdam (EUR) (0.05)
    Innovative Therapeutics in Hemostasis Laboratory0.00
    Erasmus University Rotterdam (EUR)0.05
  5. Innovative Therapeutics in Hemostasis Laboratory and Broad Institute of MIT and Harvard (0.03)
    Innovative Therapeutics in Hemostasis Laboratory0.00
    Broad Institute of MIT and Harvard0.03
  6. Innovative Therapeutics in Hemostasis Laboratory and University of Tartu (UT) (0.03)
    Innovative Therapeutics in Hemostasis Laboratory0.00
    University of Tartu (UT)0.02
  7. Innovative Therapeutics in Hemostasis Laboratory and University of Helsinki (0.02)
    Innovative Therapeutics in Hemostasis Laboratory0.00
    University of Helsinki0.02
  8. Innovative Therapeutics in Hemostasis Laboratory and Kyoto University (0.02)
    Innovative Therapeutics in Hemostasis Laboratory0.00
    Kyoto University0.02
  9. Innovative Therapeutics in Hemostasis Laboratory and The University of Edinburgh (0.02)
    Innovative Therapeutics in Hemostasis Laboratory0.00
    The University of Edinburgh0.02
  10. Innovative Therapeutics in Hemostasis Laboratory and Institute for Molecular Medicine Finland (FIMM) (0.02)
    Innovative Therapeutics in Hemostasis Laboratory0.00
    Institute for Molecular Medicine Finland (FIMM)0.02

Relationships

Partner Institutions

Innovative Therapeutics in Hemostasis Laboratory is a research collaboration whose article contributions are accrued to its participating partner institutions below.